eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
abstract:
Original paper

Glucocorticoid receptors: The key of the response to steroid therapy in autoimmune hepatitis

Mohamed A. S. El-Guindi
1
,
Haidy M. Zakaria
2
,
Doha M. Taie
3
,
Mohammed A. Khedr
1
,
Nermin M. Adawy
1
,
Basma M. Abd-Elaati
1

  1. Department of Pediatric Hepatology, Gastroenterology and Nutrition, National Liver Institute, Menoufia University, Shebin El-Kom, Menoufia, Egypt
  2. Department of Clinical Research and Health Development, Menoufia Directorate of Health Affairs, Ministry of Health and Population, Shebin El-Kom, Menoufia, Egypt
  3. Department of Histopathology, National Liver Institute, Menoufia University, Shebin El-Kom, Menoufia, Egypt
Clin Exp HEPATOL 2024; 10, 2
DOI: https://doi.org/10.5114/ceh.2024.140322
Online publish date: 2024/06/18
View full text Get citation
 
PlumX metrics:
Aim of the study:
This study was performed to investigate the hepatic expression of glucocorticoid receptors (GR) and 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) in pediatric autoimmune hepatitis (AIH) patients and its relation to the steroid response.

Material and methods:
This study included 100 patients diagnosed with AIH on immunosuppressive therapy with different responses to treatment. The patients were subjected to full history taking and thorough clinical examination, laboratory investigations, abdominal ultrasound and liver biopsy for histopathological evaluation and assessment of the hepatic expression of GR and 11β-HSD1.

Results:
Out of the 100 cases, 82 cases showed a complete response, 11 a partial response and 7 cases were non-responders. The sex, age distribution and clinical presentation of the disease were comparable among the different response groups. Glucocorticoid receptors reactivity was significantly more intense in patients with a complete response than both patients with a partial response and non-responders. 11β-HSD intensity was higher in complete and partial responders in comparison with non-responders but without significance. The percentage of patients with a GR intensity score ≥ 200 was significantly higher in patients with a complete response than patients with a partial response and non-responders (p < 0.05). The GR intensity score had a significant positive correlation with intensity of 11β-HSD (r = 0.369, p < 0.0001).

Conclusions:
Glucocorticoid receptors expression was significantly variable in children with AIH and closely related to the response to therapy. However, the 11β-HSD expression was comparable between different response groups.

keywords:

immunosuppressive therapy, autoimmune hepatitis, glucocorticoids
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.